NCT06614413

Brief Summary

The main objective is to evaluate the effect of the Mediterranean diet during pregnancy and the first two years of the child\'s life on the child\'s neurodevelopment and behavior (externalizing and internalizing disorders) measured at one and a half and two years. Secondary objectives are to evaluate the effect of the Mediterranean diet on: body composition at two years of age in infants (densitometry) and of the mother at 3 months postpartum, the incidence of allergic disease in infants, the fetal and infant ́s growth and metabolic risk in the mother during pregnancy and in the boy/girl at two years (fasting glucose: insulin, HOMA), LDL and HDL cholesterol, and micronutrient status (iron, calcium, phosphorus, magnesium, sodium, potassium, chloride, selenium, zinc and LCPUFAs). Randomized controlled clinical trial with a 1:1 ratio, parallel and open label. Group 1: Mother-child binomial with nutritional intervention; Group 2: Mother-child binomial as a control group (with follow-up without intervention). Assuming a loss of 25% (10% at follow-up, 15% failure of nutritional intervention) we would need a sample size of 267 patients per group. 1. Evaluation of neurodevelopment using the Bayleys scale version -III, at 2 years of age. 2. Behavioral assessment CBCL at 1.5 and two years and BRIEF-P at two years.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
534

participants targeted

Target at P75+ for not_applicable

Timeline
34mo left

Started Oct 2024

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Oct 2024Feb 2029

First Submitted

Initial submission to the registry

September 19, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 26, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2029

Last Updated

September 26, 2024

Status Verified

September 1, 2024

Enrollment Period

4.3 years

First QC Date

September 19, 2024

Last Update Submit

September 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Neurodevelopmental assessment an behavior at 2 years old

    Neurodevelopmental assessment using the Bayleys scale version III

    Assessment at 2 years of age

Study Arms (2)

Mother-child binomial with nutritional intervention

ACTIVE COMPARATOR

Interventions will be based on dietary-nutritional advice, derived from scientific evidence: nutrition based on the Mediterranean diet (MD) and usual treatment

Other: Neurodevelopment and behaviour assesment 2 years old

Mother-child binomial as a control group (with follow-up without intervention).

PLACEBO COMPARATOR

Mother-child binomial as a control group, with follow-up without intervention.

Other: Neurodevelopment and behaviour assesment 2 years old

Interventions

Mothers: Monthly visits guided or not by nutritionist (intervention vs control group) will consist in food questionnaires and 3-day food diary collection during pregnancy. Every three months during lactation. Children: From one year of age onwards, the KIDMED questionnaire will be administered quarterly Neurodevelopment and behavior assessment 18-24 months of age

Mother-child binomial as a control group (with follow-up without intervention).Mother-child binomial with nutritional intervention

Eligibility Criteria

Sexall(Gender-based eligibility)
Gender Eligibility DetailsPregnants
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • a. Fluency in the Spanish language, singleton pregnancy

You may not qualify if:

  • Children conceived with assisted reproduction techniques
  • Fetal anomalies and congenital infections
  • Neonatal anomalies diagnosed after birth
  • Intellectual development disorder, due to clinical judgment, inability to attend visits
  • Participation in another controlled trial
  • Vegetarian diet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Miguel Saenz de Pipaon Marcos, Professor

    HOspital La Paz Institute for Health Research

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatrician; Neonatologist

Study Record Dates

First Submitted

September 19, 2024

First Posted

September 26, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

February 1, 2029

Last Updated

September 26, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

The intermediate and final data generated in the project will be uploaded to the most appropriate repositories depending on their typology and whenever possible for confidentiality issues and that does not hinder the protection of any possible intangible asset, provided that deal with Trustworthy Digital Repositories (Research Libraries Group, 2002) and follow the reference model OASIS, developed by the Consultative Committee for Space Data Systems (accredited by the ISO standard 14721:2012). In this way, these data, as well as the publications derived from the development of the project, will be deposited, among others, in the Institutional HEALTH REPository of the Carlos III Health Institute (REPISALUD, https://repisalud.isciii.es/), and in the Institutional Repository of the Ministry of Health of the Community of Madrid. Access for other researchers who may be legitimately interested will be subject in any case to their approval, complying with the requirement of open access